ARVC Evaluation and Screening


Medicare's new cardiac MRI item numbers (63395 and 63397) effective from 1 May 2018 allow greater access to MRI for further investigation of possible Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) in patients, and screening for ARVC in first degree relatives of patients with confirmed ARVC.

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

  • An inherited myocardial disease associated with paroxysmal ventricular arrhythmias and sudden cardiac death.
  • Characterized pathologically by fibro-fatty replacement of the right ventricular myocardium.
  • The second most common cause of sudden cardiac death in young people (after HOCM), causing up to 20% of sudden cardiac deaths in patients < 35 yrs of age.
  • Typically inherited as an autosomal dominant trait, with variable penetrance and expression (there is an autosomal recessive form called Naxos Disease, which is associated with woolly hair and skin changes).
  • More common in men than women (3:1) and in people of Italian or Greek descent.
  • Estimated to affect approximately 1 in 5,000 people overall.


Our dedicated team of MRI Cardiologists and Radiolologists would be happy to assist with this evaluation where indicated.